Incyte
INCY
#1213
Rank
A$26.72 B
Marketcap
A$134.31
Share price
-0.64%
Change (1 day)
48.99%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2025 (TTM): A$2.53 Billion

According to Incyte's latest financial reports the company's current earnings are A$5.14 Billion. , an increase over its 2024 earnings that were of A$0.44 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2025

Annual earnings

Year Earnings Change
2025 A$2.32 B425.68%
2024 A$0.44 B-62.04%
2023 A$1.16 B57.66%
2022 A$0.73 B-7.24%
2021 A$0.79 B-345.65%
2020 -A$0.33 Billion-147.7%
2019 A$0.68 B322.02%
2018 A$0.16 B-136.94%
2017 -A$0.44 Billion-390.76%
2016 A$0.15 B1322%
2015 A$10.55 M-115.56%
2014 -A$67.84 Million-41.4%
2013 -A$0.12 Billion87.67%
2012 -A$61.69 Million-74.9%
2011 -A$0.25 Billion843.59%
2010 -A$26.04 Million-88.68%
2009 -A$0.24 Billion1.37%
2008 -A$0.23 Billion86.16%
2007 -A$0.13 Billion17.64%
2006 -A$0.11 Billion-28.62%
2005 -A$0.15 Billion-36.1%
2004 -A$0.23 Billion-2.03%
2003 -A$0.24 Billion22.26%
2002 -A$0.19 Billion-27.39%
2001 -A$0.27 Billion198.72%
2000 -A$87.46 Million132.2%
1999 -A$37.67 Million-556.86%
1998 A$8.24 M-37.23%
1997 A$13.13 M-259.32%
1996 -A$8.25 Million-45.87%
1995 -A$15.24 Million-9.17%
1994 -A$16.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$22.84 B 882.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.24 B 512.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$35.95 B 1,445.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.54 B 439.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.22 B-90.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-A$64.17 Million-102.76%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-A$96.75 Million-104.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-A$40.58 Million-101.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$77.62 Million-103.34%๐Ÿ‡บ๐Ÿ‡ธ USA